Lincomycin Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Lincomycin Hydrochloride Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status To Be Discontinued. The shortage was first posted on Mar 26, 2026.

Shortage details

Status
To Be Discontinued
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-0355-6
Dosage Form
Injection
Presentation
Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6)
Initial Posting
Mar 26, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.